Cargando…

PET/CT planning during chemoradiotherapy for esophageal cancer

PURPOSE: To evaluate the usefulness of positron emission tomography/computed tomography (PET/CT) for field modification during radiotherapy in esophageal cancer. MATERIALS AND METHODS: We conducted a retrospective study on 33 patients that underwent chemoradiotherapy (CRT). Pathologic findings were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seol, Ki Ho, Lee, Jeong Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977129/ https://www.ncbi.nlm.nih.gov/pubmed/24724049 http://dx.doi.org/10.3857/roj.2014.32.1.31

Ejemplares similares

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort
por: Brose, Alexander, et al.
Publicado: (2023)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

Preoperative Chemoradiotherapy for Gastroesophageal Junction Adenocarcinoma Modified by PET/CT: Results of Virtual Planning Study
por: Slavik, Marek, et al.
Publicado: (2021)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Travaini, Laura L, et al.
Publicado: (2016)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

Dosimetric analysis of lymphopenia during chemoradiotherapy for esophageal cancer
por: Newman, Neil B., et al.
Publicado: (2020)

Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Oh, Jinju, et al.
Publicado: (2019)

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer
por: Lee, Jeong Won, et al.
Publicado: (2021)

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors
por: Lu, W, et al.
Publicado: (2015)

Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015)

Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy
por: Shi, Yan-Jie, et al.
Publicado: (2022)

Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer
por: Guo, Yanluan, et al.
Publicado: (2017)

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT
por: Goense, Lucas, et al.
Publicado: (2018)

Total Lesion Glycolysis Using (18)F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer
por: Hong, Ji Hyung, et al.
Publicado: (2016)

Cytomegalovirus esophagitis developing during chemoradiotherapy for esophageal cancer: two case reports
por: Umemoto, Kumiko, et al.
Publicado: (2016)

Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy
por: Yuan, Zhigang, et al.
Publicado: (2021)

PET/CT and hepatic radiation injury in esophageal cancer patients
por: Iyer, Revathy B., et al.
Publicado: (2007)

The Role of PET-Based Radiomic Features in Predicting Local Control of Esophageal Cancer Treated with Concurrent Chemoradiotherapy
por: Xiong, Junfeng, et al.
Publicado: (2018)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy
por: Demir, Metin, et al.
Publicado: (2022)

Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study
por: Lee, Soo Jung, et al.
Publicado: (2009)

[F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
por: Walter, Franziska, et al.
Publicado: (2020)

FDG-PET/CT–based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2013)

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using (18)F-FDG PET-CT imaging: a prospective cohort study
por: Brenner, Baruch, et al.
Publicado: (2022)

Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2019)

Preoperative chemoradiotherapy for locoregional esophageal cancer: preliminary report.
por: Kim, S. B., et al.
Publicado: (1995)

Diffusion-weighted MRI and (18)F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2021)

Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
por: Kim, Suzy, et al.
Publicado: (2014)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
por: Gupta, Arunima, et al.
Publicado: (2014)

Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT
por: Pan, Yi, et al.
Publicado: (2015)

Prognostic value of FDG PET/CT during radiotherapy in head and neck cancer patients
por: Kim, Suzy, et al.
Publicado: (2018)

Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
por: Parlak, Cem, et al.
Publicado: (2012)

The Diagnostic Utility of Prone Position Chest CT for the Evaluation of Esophageal Cancer
por: Lee, Jong Eun, et al.
Publicado: (2020)

Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients
por: Nam, Su Youn, et al.
Publicado: (2020)

Role of (18)FDG PET/CT metabolic parameters in predicting hematological toxicity during chemoradiotherapy for locally advanced cervical cancer
por: Meng, Tianyu, et al.
Publicado: (2022)

NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial)
por: van Heijl, Mark, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_bi0uitplvq54pios8kfjdrauea